315
Views
11
CrossRef citations to date
0
Altmetric
Research Article

PVP and surfactant combined carrier as an effective absorption enhancer of poorly soluble astilbin in vitro and in vivo

, , , , &
Pages 237-243 | Received 15 Oct 2012, Accepted 30 Nov 2012, Published online: 28 Jan 2013

References

  • Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv 2008;60:673–91
  • Bunjes H. Lipid nanoparticles for the delivery of poorly water-soluble drugs. J Pharm Pharmacol 2010;62:1637–45
  • Gaudana R, Parenky A, Vaishya R, et al. Development and characterization of nanoparticulate formulation of a water soluble prodrug of dexamethasone by HIP complexation. J Microencapsul 2011;28:10–20
  • Vikas B, Mushir A, Javed A. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int J Pharm 2010;403:46–56
  • Vithlani S, Sarraf S, Chaw CS. Formulation and in vitro evaluation of self-emulsifying formulations of cinnarizine. Drug Dev Ind Pharm 2012;38:1188–94
  • Laitinen R, Suihko E, Bjorkqvist M, et al. Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation. Drug Dev Ind Pharm 2010;36:601–13
  • Rose-Marie D, Handan H, Yatindra J, et al. Development of clinical dosage forms for a poorly water soluble drug. I: application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004;93:1165–75
  • Verheyen S, Blaton N, Kinget R, et al. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 2002;249:45–58
  • DiNunzio JC, Hughey JR, Brough C, et al. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol dispersing. Drug Dev Ind Pharm 2010;36:1064–78
  • Mehanna MM, Motawaa AM, Samaha MW. In sight into tadalafil–block copolymer binary solid dispersion: mechanistic investigation of dissolution enhancement. Int J Pharm 2010;402:78–88
  • Dannenfelser RM, He H, Joshi Y, et al. Development of clinical dosage forms for a poorly water soluble drug: application of polyethylene glycol polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004;93:1165–75
  • Feng J, Xu L, Gao R, et al. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm. 2012;38:735–43
  • Dave RH, Patel AD, Donahue E, et al. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin. Drug Dev Ind Pharm 2012;38:930–9
  • Tschesehe R, Delhvi S, Sepulveda S, Breitmaier E. EucryPhin, a new chromone rhamnoside from the bark of EucryPhia cordifolia. Phytochemistry 1979;18:867–9
  • Moulari B, Pellequer Y, Lboutounne H, et al. Isolation and in vitro antibacterial activity of astilbin, the bioactive flavanone from the leaves of Harungana madagascariensis Lam. ex Poir. (Hypericaceae). J Ethnopharmacol 2006;106:272–8
  • Luciane GBP, Fernando P, João BF, et al. Biological activity of astilbin from Dimorphandra mollis against Anticarsia gemmatalis and Spodoptera frugiperda. Pest Manag Sci 2002;58:503–7
  • Kimura Y, Sumiyoshi M, Sakanaka M. Effects of Astilbe thunbergii rhizomes on wound healing. Part 1: isolation of promotional effectors from Astilbe thunbergii rhizomes on burn wound healing. J Ethnopharmacol 2007;109:72–7
  • Eliane C, João BC, Franco Delle M, Rosendo AY. Isolation, chemical identification and pharmacological evaluation of eucryphin, astilbin and engelitin obtained from the bark of Hymenaea martiana. Pharm Biol 1993;31:38–46
  • Cao ZZ, Yi YJ, Hong WQ. Studies on the chemical constituents of Smilax Glabra Roxb(I). Chin Traditional Herbal Drugs 1993;24:234–5
  • Yuan JZ, Dou DQ, Chen YJ, et al. Studies on dihydroflavonol glycosides from rhizome of Smilax glabra. Chin J Chin Mater Med 2004;29:867–70
  • Eugene KT, Vernon LS. Astilbin engeletin in grapes and wine. Phytoehemist 1983;22:619–20
  • Shang XY, Li S, Wang YH, et al. Dihydroflavonol glycosides and flavan-3-ols from Bauhinia aurea. Chin J Chin Mater Med 2007;32:815–18
  • Shu XS, Gao ZH, Yang XL. The anti-inflammation effects of Smilax china ethylacetate extract in rats and mice. Chin J Chin Mater Med 2006;31:239–342
  • Zhou YL, Yan H, Zhong XQ, et al. Fingerprint of hydropholic components in Smilax china. Chin Traditional Herbal Drugs 2008a;39:1246–8
  • Zhou YL, Zhong XQ, Yan H, et al. Content determination of astilbin in four kinds of the genus Smilax by HPLC. Chin J Chin Mater Med 2008b;33:959–61
  • Qu J, Zhou J, Hou WB, Shou GX. Determination of astilbin and engeletin in Engelhardia roxburghiana Wall leaf. Chin Traditional Herbal Drugs 2009;40:306–7
  • Wang C, Zhu LP, Yang JZ, et al. Chemical constituents from Sarcandra glabra. Chin J Chin Mater Med 2010;35:714–17
  • Ken O, Hiroki O, Keisuke S. First synthesis of astilbin, biologically active glycosyl flavonoid isolated from Chinese folk medicine. Tetrahedron Lett 2000;41:5537–41
  • Xu Q, Sun Y. Novel immunosuppression stemming from the selective activity of Chinese herbal drugs. Prog Chem 2009;21:55–62
  • Xu Q, Wu F, Cao J, et al. Astilbin selectively induces dysfunction of liver infiltrating cells-novel protection from liver damage. Eur J Pharmacol 1999;377:93–100
  • Yan R, Xu Q. Astilbin selectively facilitates the apoptosis of interleukin-2-dependent phytohemagglutinin-activated jurkat cells. Pharmacol Res 2001;44:135–9
  • Cai Y, Chen T, Xu Q. Astilbin suppresses delayed-type hypersensitivity by inhibiting lymphocyte migration. J Pharm Pharmacol 2003;55:691–6
  • Wang J, Zhao Y, Xu Q. Astilbin prevents concanavalin A-induced liver injury by reducing TNF-α production and T lymphocyte adhesion. J Pharm Pharmacol 2004;56:495–502
  • Fei M, Wu X, Xu Q. Astilbin inhibits contact hypersensitivity through negative cytokine regulation distinct from cyclosporine A. J allergy Clin Immunol 2005;116:1350–6
  • Xu Q, Saiki I, Chen T, Komatsu K. Immuno suppressive agents. US: 6, 531, 505, 11 March 2003
  • Chen T, Xu Q, Wang SY. Glabrous greenbrier total saponin extract and its prepn and use [P]. CN: 200510095149.3, 17 May 2006
  • Guidance for Industry. Waiver of in vitro bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Washington (DC): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2000
  • Wang XD, Meng MX, Gao LB, et al. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm 2009;378:1–8
  • Guo JM, Xu Q, Chen T. Quantitative determination of astilbin in rabbit plasma by liquid chromatography. J Chromatogr B 2004;805:357–60
  • Guo JM, Qian F, Li JX, et al. Identification of a new metabolite of astilbin, 3′-O-methylastilbin, and its immunosuppressive activity against contact dermatitis. Clin Chem 2007;53:465–71
  • He Y, Nie JY, Xu MW, et al. Preparation and physicochemical examination of astilbin solid dispersion. Chin Traditional Pat Med 2010;32:1695–8
  • Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer–surfactant combinations using solubility parameters and testing the processability. Int J Pharm 2007;328:119–29

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.